See more : China CBM Group Company Limited (8270.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Mytrex Health Technologies, Inc. (4431.TWO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Mytrex Health Technologies, Inc., a leading company in the Industrial – Machinery industry within the Industrials sector.
- ATHENS INTERNATIONAL AIRPORT S. (AIA.AT) Income Statement Analysis – Financial Results
- Accrete Inc. (4395.T) Income Statement Analysis – Financial Results
- VBC Ferro Alloys Limited (VBCFERROQ.BO) Income Statement Analysis – Financial Results
- Sinclairs Hotels Limited (SINCLAIR.NS) Income Statement Analysis – Financial Results
- Kaisa Prosperity Holdings Limited (2168.HK) Income Statement Analysis – Financial Results
Mytrex Health Technologies, Inc. (4431.TWO)
About Mytrex Health Technologies, Inc.
Mytrex Health Technologies, Inc. engages in the manufacturing, processing, and sale of various filter non-woven fabrics in Taiwan, rest of Asia, Europe, and internationally. The company provides electrostatic filtration materials for medical and industrial mask media, and other filtration applications; and composite nonwoven products for coolant and air filter, vacuum filter bag, HEPA and cabin filter, and water filtration compound material applications. It also offers thermal insulation products for glove, sock, shoe, hat, clothing material, and mask insulation material applications; and linen laundry and leasing, logistic, and medical supplies for hospitals. In addition, the company sells pharmaceuticals and medical hygiene materials; and manages medical clothing products. Mytrex Health Technologies, Inc. was founded in 1990 and is based in Taoyuan, Taiwan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 1.29B | 1.47B | 291.62M | 1.02B | 398.42M |
| Cost of Revenue | 1.10B | 1.23B | 251.48M | 395.12M | 337.53M |
| Gross Profit | 192.35M | 239.40M | 40.14M | 628.52M | 60.89M |
| Gross Profit Ratio | 14.88% | 16.27% | 13.76% | 61.40% | 15.28% |
| Research & Development | 12.30M | 16.40M | 1.98M | 0.00 | 167.00K |
| General & Administrative | 132.57M | 137.94M | 26.22M | 152.42M | 23.96M |
| Selling & Marketing | 161.68M | 172.80M | 27.43M | 36.24M | 26.25M |
| SG&A | 294.25M | 310.74M | 53.65M | 188.66M | 55.46M |
| Other Expenses | -43.65M | -11.02M | 3.63M | 4.59M | 0.00 |
| Operating Expenses | 192.35M | 286.27M | 55.62M | 188.51M | 53.99M |
| Cost & Expenses | 1.36B | 1.52B | 307.10M | 583.63M | 391.52M |
| Interest Income | 2.30M | 1.15M | 670.00K | 186.00K | 446.00K |
| Interest Expense | 6.24M | 5.24M | 1.58M | 1.46M | 1.33M |
| Depreciation & Amortization | 59.51M | 106.51M | 50.60M | 27.46M | 15.59M |
| EBITDA | 46.04M | 49.89M | 38.58M | 471.83M | 21.02M |
| EBITDA Ratio | 3.56% | 3.38% | 13.22% | 46.09% | 5.28% |
| Operating Income | -71.83M | -56.74M | -12.04M | 444.38M | 5.43M |
| Operating Income Ratio | -5.56% | -3.86% | -4.13% | 43.41% | 1.36% |
| Total Other Income/Expenses | 14.65M | -15.00M | 1.86M | 2.91M | 894.00K |
| Income Before Tax | -57.18M | -61.86M | -13.60M | 441.16M | 6.34M |
| Income Before Tax Ratio | -4.42% | -4.20% | -4.66% | 43.10% | 1.59% |
| Income Tax Expense | 1.11M | 7.10M | 450.00K | 89.57M | 1.56M |
| Net Income | -56.22M | -91.90M | -14.01M | 352.27M | 9.32M |
| Net Income Ratio | -4.35% | -6.25% | -4.80% | 34.41% | 2.34% |
| EPS | -1.54 | -2.52 | -0.38 | 10.97 | 0.30 |
| EPS Diluted | -1.54 | -2.52 | -0.38 | 10.71 | 0.29 |
| Weighted Avg Shares Out | 36.54M | 36.54M | 36.54M | 32.11M | 30.97M |
| Weighted Avg Shares Out (Dil) | 36.54M | 36.54M | 36.54M | 32.90M | 31.68M |
Source: https://incomestatements.info
Category: Stock Reports